Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer

Video

Christina Tan, MD, MPH, discusses the potential impact of the novel coronavirus on patients with cancer.

Christina Tan, MD, MPH, state epidemiologist, assistant commissioner, New Jersey Department of Health, discusses the potential impact of the novel coronavirus (COVID-19) on patients with cancer. The CDC just stated the name of this new strain is COVID-19.

Though many questions remain regarding COVID-19, individuals with weakened immune systems appear to be at greater risk of developing complications associated with COVID-19, says Tan. Individuals who fall into this category include those with cancer, cardiac or lung disease, and women who are pregnant.

Additionally, influenza poses a heightened threat to these individuals, says Tan.

Hygienic practices like frequent hand washing, covering one’s coughs and sneezes, staying home if unwell, and contacting a healthcare provider if feeling sick may prevent the spread of these diseases, says Tan. Immunocompromised individuals should also be advised to get a flu shot to protect themselves against some of the most common flu strains.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD